(VVX) V2X - Overview
Sector: Industrials | Industry: Aerospace & Defense | Exchange: NYSE (USA) | Market Cap: 2.136m USD | Total Return: 39.7% in 12m
Stock
Defense Support, Mission Solutions, Supply Chain, Modernization
Total Rating 47
Risk 67
Buy Signal -0.01
Market Cap:
2,136m
Avg Trading Vol: 33.6M USD
Avg Trading Vol: 33.6M USD
ATR:
3.76%
Peers RS (IBD): 74.0
Peers RS (IBD): 74.0
Risk 5d forecast
Volatility40.4%
Rel. Tail Risk-13.8%
Reward TTM
Sharpe Ratio0.92
Alpha22.26
Character TTM
Beta0.830
Beta Downside1.274
Drawdowns 3y
Max DD38.90%
CAGR/Max DD0.53
EPS (Earnings per Share)
EPS CAGR: -21.05%
EPS Trend: 58.4%
EPS Trend: 58.4%
Last SUE: -3.27
Qual. Beats: 0
Qual. Beats: 0
Revenue
Rev. CAGR: 29.93%
Rev. Trend: 73.4%
Rev. Trend: 73.4%
Last SUE: 0.27
Qual. Beats: 0
Qual. Beats: 0
Description: VVX V2X
March 04, 2026
V2X, Inc. (VVX) provides mission-critical solutions and support services to defense clients globally. The company operates in the Aerospace & Defense sector, a market characterized by long contract cycles and government procurement processes.
V2X offers a range of integrated services, including supply chain management, platform modernization, and national security support. This business model often involves complex logistics and specialized technical expertise.
Incorporated in 2014 and headquartered in Reston, Virginia, V2X is a subsidiary of Vertex Aerospace Holdco LLC. For further insights into VVXs operational details, ValueRay offers comprehensive analysis.
- Defense spending budgets directly impact V2X contract awards
- International geopolitical stability influences demand for V2X services
- Supply chain disruptions increase operational costs for V2X
- Government contract renewals are crucial for V2X revenue continuity
- Labor market availability affects V2X project staffing and costs
Piotroski VR‑10 (Strict, 0-10)
3.5
| Net Income: 77.9m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.05 > 0.02 and ΔFCF/TA -2.49 > 1.0 |
| NWC/Revenue: 4.90% < 20% (prev 2.41%; Δ 2.49% < -1%) |
| CFO/TA 0.05 > 3% & CFO 182.0m > Net Income 77.9m |
| Net Debt (800.8m) to EBITDA (295.2m): 2.71 < 3 |
| Current Ratio: 1.22 > 1.5 & < 3 |
| Outstanding Shares: last quarter (31.8m) vs 12m ago -0.47% < -2% |
| Gross Margin: 8.33% > 18% (prev 0.08%; Δ 825.5% > 0.5%) |
| Asset Turnover: 135.4% > 50% (prev 133.9%; Δ 1.52% > 0%) |
| Interest Coverage Ratio: 2.23 > 6 (EBITDA TTM 295.2m / Interest Expense TTM 81.7m) |
Altman Z''
1.28
| A: 0.06 (Total Current Assets 1.24b - Total Current Liabilities 1.02b) / Total Assets 3.39b |
| B: 0.10 (Retained Earnings 343.4m / Total Assets 3.39b) |
| C: 0.06 (EBIT TTM 182.6m / Avg Total Assets 3.31b) |
| D: 0.15 (Book Value of Equity 335.8m / Total Liabilities 2.30b) |
| Altman-Z'' Score: 1.28 = BB |
Beneish M
-3.09
| DSRI: 1.00 (Receivables 738.9m/710.1m, Revenue 4.48b/4.32b) |
| GMI: 0.95 (GM 8.33% / 7.93%) |
| AQI: 0.97 (AQ_t 0.61 / AQ_t-1 0.63) |
| SGI: 1.04 (Revenue 4.48b / 4.32b) |
| TATA: -0.03 (NI 77.9m - CFO 182.0m) / TA 3.39b) |
| Beneish M-Score: -3.09 (Cap -4..+1) = AA |
What is the price of VVX shares?
As of April 01, 2026, the stock is trading at USD 68.50 with a total of 288,171 shares traded.
Over the past week, the price has changed by -0.09%, over one month by -3.48%, over three months by +25.57% and over the past year by +39.65%.
Over the past week, the price has changed by -0.09%, over one month by -3.48%, over three months by +25.57% and over the past year by +39.65%.
Is VVX a buy, sell or hold?
V2X has received a consensus analysts rating of 3.82.
Therefore, it is recommended to buy VVX.
- StrongBuy: 5
- Buy: 2
- Hold: 2
- Sell: 1
- StrongSell: 1
What are the forecasts/targets for the VVX price?
| ISSUER | TARGET | UP/DOWN |
|---|---|---|
| Wallstreet Target Price | 75.9 | 10.8% |
| Analysts Target Price | 75.9 | 10.8% |
VVX Fundamental Data Overview
March 30, 2026
P/E Trailing = 27.8857 P/E Forward = 11.7096
P/S = 0.4769
P/B = 1.9558
Revenue TTM = 4.48b USD
EBIT TTM = 182.6m USD
EBITDA TTM = 295.2m USD
Long Term Debt = 1.08b USD (from longTermDebt, last quarter)
Short Term Debt = 25.7m USD (from shortTermDebt, last quarter)
Debt = 1.17b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 800.8m USD (from netDebt column, last quarter)
Enterprise Value = 2.94b USD (2.14b + Debt 1.17b - CCE 369.0m)
Interest Coverage Ratio = 2.23 (Ebit TTM 182.6m / Interest Expense TTM 81.7m)
EV/FCF = 17.27x (Enterprise Value 2.94b / FCF TTM 170.1m)
FCF Yield = 5.79% (FCF TTM 170.1m / Enterprise Value 2.94b)
FCF Margin = 3.80% (FCF TTM 170.1m / Revenue TTM 4.48b)
Net Margin = 1.74% (Net Income TTM 77.9m / Revenue TTM 4.48b)
Gross Margin = 8.33% ((Revenue TTM 4.48b - Cost of Revenue TTM 4.11b) / Revenue TTM)
Gross Margin QoQ = 8.62% (prev 8.10%)
Tobins Q-Ratio = 0.87 (Enterprise Value 2.94b / Total Assets 3.39b)
Interest Expense / Debt = 1.80% (Interest Expense 21.0m / Debt 1.17b)
Taxrate = 20.46% (5.86m / 28.6m)
NOPAT = 145.3m (EBIT 182.6m * (1 - 20.46%))
Current Ratio = 1.22 (Total Current Assets 1.24b / Total Current Liabilities 1.02b)
Debt / Equity = 1.08 (Debt 1.17b / totalStockholderEquity, last quarter 1.08b)
Debt / EBITDA = 2.71 (Net Debt 800.8m / EBITDA 295.2m)
Debt / FCF = 4.71 (Net Debt 800.8m / FCF TTM 170.1m)
Total Stockholder Equity = 1.07b (last 4 quarters mean from totalStockholderEquity)
RoA = 2.35% (Net Income 77.9m / Total Assets 3.39b)
RoE = 7.30% (Net Income TTM 77.9m / Total Stockholder Equity 1.07b)
RoCE = 8.50% (EBIT 182.6m / Capital Employed (Equity 1.07b + L.T.Debt 1.08b))
RoIC = 6.69% (NOPAT 145.3m / Invested Capital 2.17b)
WACC = 6.26% (E(2.14b)/V(3.31b) * Re(8.90%) + D(1.17b)/V(3.31b) * Rd(1.80%) * (1-Tc(0.20)))
Discount Rate = 8.90% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 33.33 | Cagr: 0.60%
[DCF] Terminal Value 87.52% ; FCFF base≈199.0m ; Y1≈245.5m ; Y5≈418.9m
[DCF] Fair Price = 331.7 (EV 11.17b - Net Debt 800.8m = Equity 10.37b / Shares 31.3m; r=6.26% [WACC]; 5y FCF grow 25.0% → 3.0% )
EPS Correlation: 58.37 | EPS CAGR: -21.05% | SUE: -3.27 | # QB: 0
Revenue Correlation: 73.39 | Revenue CAGR: 29.93% | SUE: 0.27 | # QB: 0
EPS next Quarter (2026-06-30): EPS=1.41 | Chg7d=+0.130 | Chg30d=+0.130 | Revisions Net=+5 | Analysts=10
EPS current Year (2026-12-31): EPS=5.82 | Chg7d=+0.122 | Chg30d=+0.122 | Revisions Net=+3 | Growth EPS=+11.0% | Growth Revenue=+6.4%
EPS next Year (2027-12-31): EPS=6.59 | Chg7d=+0.141 | Chg30d=+0.141 | Revisions Net=+5 | Growth EPS=+13.3% | Growth Revenue=+5.5%
[Analyst] Revisions Ratio: +0.71 (6 Up / 1 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 5.3% (Discount Rate 8.9% - Earnings Yield 3.6%)
[Growth] Growth Spread = +4.4% (Analyst 9.7% - Implied 5.3%)